格隆汇1月7日丨神工股份(688233.SH)公布，2026年1月7日，股东更多亮照明通过大宗交易方式减持公 司股份1,243,200股，占公司总股本的比例为0.73%。股东更多亮照明股份由35,303,481股变动为 34,060,281股，占公司总股本的比例由20.73%减少至20.00%，股东权益变动触及5%的整数倍。 ...

格隆汇1月7日丨神工股份(688233.SH)公布，2026年1月7日，股东更多亮照明通过大宗交易方式减持公 司股份1,243,200股，占公司总股本的比例为0.73%。股东更多亮照明股份由35,303,481股变动为 34,060,281股，占公司总股本的比例由20.73%减少至20.00%，股东权益变动触及5%的整数倍。 ...

神工股份公告称，持股5%以上股东更多亮照明履行减持计划，于2026年1月7日通过大宗交易减持 124.32万股，占总股本0.73%。其持股由3530.35万股降至3406.03万股，占比从20.73%减至20.00%，权益 变动触及5%整数倍。本次减持不触及要约收购，不影响控股权。截至公告披露日，减持计划尚未实施 完毕。 ...

第4笔成交价格为70.00元，成交22.24万股，成交金额1,556.80万元，溢价率为-14.63%，买方营业部为长 江证券股份有限公司上海分公司，卖方营业部为上海证券有限责任公司佛山南海永胜西路证券营业部。 第2笔成交价格为70.00元，成交42.75万股，成交金额2,992.50万元，溢价率为-14.63%，买方营业部为兴 业证券股份有限公司上海锦康路证券营业部，卖方营业部为上海证券有限责任公司佛山南海永胜西路证 券营业部。 第3笔成交价格为70.00元，成交36.88万股，成交金额2,581.60万元，溢价率为-14.63%，买方营业部为国 泰海通证券股份有限公司北京望京阜通东大街证券营业部，卖方营业部为上海证券有限责任公司佛山南 海永胜西路证券营业部。 1月7日，神工股份收涨10.95%，收盘价为82.00元，发生4笔大宗交易，合计成交量124.32万股，成交金 额8702.4万元。 第1笔成交价格为70.00元，成交22.45万股，成交金额1,571.50万元，溢价率为-14.63%，买方营业部为兴 业证券股份有限公司上海分公司，卖方营业部为上海证券有限责任公司佛山南海永胜西路证券营业部。 进一步 ...

Market Overview - The A-share market showed a strong performance with the Shanghai Composite Index approaching 4100 points, while the ChiNext Index and Shenzhen Component Index rose by 0.41% and 0.35% respectively, with a total trading volume of 1.85 trillion yuan, an increase of 538 billion yuan compared to the previous trading day [1] Semiconductor Sector - The semiconductor index rose by 2.20%, reaching 8181.14 points, with notable stocks such as ChipSource Microelectronics and Nanda Optoelectronics both increasing by 20% [2][3] Brain-Computer Interface Sector - The brain-computer interface sector continued to perform strongly, with companies like Innovation Medical and Nanjing Panda achieving three consecutive trading limit ups. Strong Brain Technology completed approximately 2 billion yuan in financing, marking it as the second-largest financing in the brain-computer interface field after Neuralink [4] Hong Kong Market - The Hong Kong market saw declines, with the Hang Seng Index and Hang Seng China Enterprises Index both dropping nearly 1%. Alibaba fell by nearly 4%, while companies like WuXi AppTec and China Life rose over 3% [5] Precious Metals Market - International precious metals experienced a downturn, with spot gold dropping below 4480 USD per ounce, while spot silver saw a slight decrease but maintained a year-to-date increase of 13% [6] Base Metals Market - The base metals market showed a strong performance, with SHFE nickel rising nearly 8% and SHFE tin increasing by nearly 6%. The LME copper reached a record high, driven by supply concerns [7]

Investment Rating - The investment rating for the company is "Buy" (maintained) [7] Core Insights - The company is a leading supplier of single crystal silicon materials for integrated circuit etching, holding approximately 15% of the global market share. It is expected to benefit from the overall supply chain improvement driven by the storage industry's growth cycle, leading to potentially exceeding performance expectations [1][2] - The company has established a strong position in the semiconductor materials sector since its inception in 2013, with a product matrix that includes large diameter etching silicon materials, silicon components, and large-size silicon wafers. Its integrated R&D and production capabilities provide a sustainable competitive advantage [2] - The demand for large diameter silicon materials is expected to rise due to increased utilization in storage chip manufacturing, particularly as the global tech giants ramp up capital expenditures for computing centers. This trend is anticipated to create structural shortages in storage chip capacity [3] - The company has a stable export market for its large diameter silicon materials, with products already integrated into major domestic etching equipment manufacturers and wafer fabs. Its product range covers 14-inch to 22-inch specifications, catering to a broad customer base across key semiconductor regions [4] Financial Projections - Revenue forecasts for the company from 2025 to 2027 are projected at 450 million, 800 million, and 1.32 billion yuan, representing year-on-year growth rates of 47.2%, 78.5%, and 65.3% respectively. Net profit is expected to reach 100 million, 260 million, and 440 million yuan, with growth rates of 152.9%, 152.8%, and 68.4% respectively [12][14] - The estimated P/E ratios based on the closing price as of January 6, 2026, are 120.9, 47.8, and 28.4 for the years 2025, 2026, and 2027 respectively [12]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688233 证券简称：神工股份 公告编号：2025-046 锦州神工半导体股份有限公司关于与专业机构共同投资设立产业基金的进展公告 托管人名称：招商银行股份有限公司 备案日期：2025年12月29日 备案编码：SBMQ95 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、参与设立的投资基金情况概述 锦州神工半导体股份有限公司（以下简称"神工股份"或"公司"）已于2025年12月1日、2025年12月4日召 开了第三届董事会战略委员会第三次会议、第三届董事会审计委员会第十次会议、第三届董事会第十次 会议审议通过了《关于拟与专业机构共同投资设立产业基金的议案》，同意公司与国泰君安创新投资有 限公司（以下简称"国泰君安创新投资"）、江城产业投资基金（武汉）有限公司（以下简称"江城基 金"）、湖北国芯产业投资管理有限责任公司（以下简称"国芯投资"）开展战略合作，共同设立江城国 泰海通神工（武汉）创业投资基金合伙企业（有限合伙）（以下简称"创投基金"）。 具体内容详见 ...

证券代码：688233 证券简称：神工股份 公告编号：2025-046 锦州神工半导体股份有限公司（以下简称"神工股份"或"公司"）已于 2025 年 12 月 1 日、2025 年 12 月 4 日召开了第三届董事会战略委员会第三次会 议、第三届董事会审计委员会第十次会议、第三届董事会第十次会议审议通过 了《关于拟与专业机构共同投资设立产业基金的议案》，同意公司与国泰君安 创新投资有限公司（以下简称"国泰君安创新投资"）、江城产业投资基金 （武汉）有限公司（以下简称"江城基金"）、湖北国芯产业投资管理有限责 任公司（以下简称"国芯投资"）开展战略合作，共同设立江城国泰海通神工 （武汉）创业投资基金合伙企业（有限合伙）（以下简称"创投基金"）。 具体内容详见公司于 2025 年 12 月 5 日、12 月 17 日披露于上海证券交易 所网站（www.sse.com.cn）的《锦州神工半导体股份有限公司关于与专业机构 共同投资设立产业基金的公告》《锦州神工半导体股份有限公司关于与专业机 构共同投资设立产业基金的进展公告》。 二、参与设立的投资基金进展情况 公司于近日收到基金管理人国泰君安创新投资的通知，创投基金 ...

Core Viewpoint - The semiconductor sector experienced a rise of 1.62% on December 30, with N Qiang leading the gains, while the overall market showed mixed results with the Shanghai Composite Index closing at 3965.12, down 0.0% [1]. Group 1: Stock Performance - N Qiang (688809) closed at 226.01, up 165.61% with a trading volume of 180,700 shares [1]. - Other notable gainers include: - Saiwei Electronics (300456) at 62.15, up 10.47% with a volume of 1,204,000 shares [1]. - New Xiangwei (688593) at 20.90, up 9.54% with a volume of 215,300 shares [1]. - Dongxin Co. (688110) at 134.91, up 9.49% with a volume of 385,100 shares [1]. - Zhuosheng Micro (300782) at 82.40, up 8.09% with a volume of 384,000 shares [1]. Group 2: Capital Flow - The semiconductor sector saw a net inflow of 432 million yuan from institutional investors, while retail investors contributed a net inflow of 1.774 billion yuan [2]. - Notable capital flows include: - N Qiang (688809) had a net inflow of 18.24 billion yuan from institutional investors, but a net outflow of 1.173 billion yuan from retail investors [3]. - Saiwei Electronics (300456) experienced a net inflow of 588 million yuan from institutional investors, with a net outflow of 110 million yuan from retail investors [3]. - Haiguang Information (688041) had a net inflow of 423 million yuan from institutional investors [3].

Core Viewpoint - The launch of the NeuViz P10 photon counting CT by Neusoft Medical marks a significant advancement in China's high-end medical imaging equipment, showcasing the country's transition from following to leading in this technology [1][2]. Group 1: Product Innovation - The NeuViz P10 is the world's first 8cm wide photon counting CT, filling a technological gap in high-end medical imaging equipment in China [1]. - The device features a spatial resolution of 50 lp/cm and reduces radiation dosage by over 90%, significantly decreasing the amount of contrast agent used [2]. - It incorporates a new generation supersonic platform for cardiac imaging and an intelligent platform with 17 proprietary AI technologies, enhancing diagnostic efficiency and patient experience [2][3]. Group 2: Market Position and Growth - Since 2000, the market share of domestic CT equipment has risen from nearly zero to over 50% by the end of 2024, driven by policy support and growing market recognition [4]. - Neusoft Medical's partnership with General Technology Group has accelerated its R&D and internationalization efforts, shortening the development cycle of NeuViz P10 by approximately 18 months [4]. Group 3: International Expansion - Neusoft Medical is expanding its imaging cloud platform across provinces in China and plans to promote comprehensive solutions in Belt and Road Initiative countries [4]. - The company is building a high-end imaging network in Kazakhstan and establishing cross-border collaboration laboratories in Africa [4]. Group 4: Future Outlook - The company envisions that "China Intelligent Manufacturing" in medical equipment will become a national treasure, contributing to the construction of a healthy China and a manufacturing powerhouse [5].